[SER140]-PLP(139-151) is a fragment of myelin proteolipid protein, induce experimental autoimmune encephalomyelitis (EAE).
CAT No: R1135
CAS No:122018-58-0
Synonyms/Alias:122018-58-0;Proteolipid protein (139-151);[SER140]-PLP(139-151);PLP(139-151)TFA;AKOS024457171;NCGC00167265-01;DA-56936;SER140-PLP(139-151)?;CAS 122018-58-0;G78392;
Chemical Name:(S,Z)-3-((Z)-(((S)-1-((2S,3Z,6Z,8S,9Z,11S,12Z,14S,15Z,18Z,20S,21Z,23S,24Z,26S)-2-((1H-imidazol-5-yl)methyl)-11-((1H-indol-3-yl)methyl)-26-amino-14-(4-aminobutyl)-4,7,10,13,16,19,22,25-octahydroxy-23-(hydroxymethyl)-27-(1H-imidazol-5-yl)-8,20-diisobutyl-3
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.